UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 1.903

Sortiert nach

Transgenerational entrepreneurship: exploring growth and performance in family firms across generations

2010

Volltextzugriff (PDF)

Advancing patient-derived organoids of prostate cancer for disease modeling and personalized medicine

European urology open science (Online), 2020-07, Vol.19, p.e1820

2020

Volltextzugriff (PDF)

627: MED12 overexpression is a frequent event in castration-resistant prostate cancer

European journal of cancer (1990), 2014-07, Vol.50, p.S149-S149

2014

Volltextzugriff (PDF)

Incidental prostate cancer prevalence at radical cystoprostatectomy—importance of the histopathological work-up

Virchows Archiv : an international journal of pathology, 2014-12, Vol.465 (6), p.629-636

2014

Volltextzugriff (PDF)

ERG rearrangement and protein expression in the progression to castration-resistant prostate cancer

Prostate cancer and prostatic diseases, 2014-06, Vol.17 (2), p.126-131

2014

Volltextzugriff (PDF)

319 COMPREHENSIVE ANALYSIS OF THE TMPRSS2-ERG TRANSLOCATION DURING PROSTATE CANCER PROGRESSION

The Journal of urology, 2012-04, Vol.187 (4), p.e129-e129

2012

Volltextzugriff (PDF)

Overexpression of the cytoprotective protein clusterin decreases radiosensitivity in the human LNCaP prostate tumour model

BJU international, 2003-09, Vol.92 (4), p.463-469

2003

Volltextzugriff (PDF)

P213 - Loss of MTAP expression by immunohistochemistry is a surrogate marker for homozygous 9p21.3 deletion in urothelial carcinoma

European urology, 2024-03, Vol.85, p.S295-S295

2024

Volltextzugriff (PDF)

Loss of MTAP expression by immunohistochemistry is a surrogate marker for homozygous 9p21.3 deletion in urothelial carcinoma

European urology, 2024-03, Vol.85, p.S295

2024

Volltextzugriff (PDF)

Parental divorce in early life and entrepreneurial performance in adulthood

Journal of business venturing, 2024-05, Vol.39 (3), p.106390, Article 106390

2024

Volltextzugriff (PDF)

Language bias in randomised controlled trials published in English and German

The Lancet (British edition), 1997-08, Vol.350 (9074), p.326-329

1997

Volltextzugriff (PDF)

A0535 - Cell-Free DNA genomic profiling and its clinical implementation in advanced prostate cancer

European urology, 2024-03, Vol.85, p.S1424-S1424

2024

Volltextzugriff (PDF)

Cell-Free DNA genomic profiling and its clinical implementation in advanced prostate cancer

European urology, 2024-03, Vol.85, p.S1424

2024

Volltextzugriff (PDF)

Stat3 Promotes Metastatic Progression of Prostate Cancer

The American journal of pathology, 2008-06, Vol.172 (6), p.1717-1728

2008

Volltextzugriff (PDF)

Financial Management of Family Businesses: Transparency - Compliance - Performance - Strategy - Governance

1, 2023

Volltextzugriff (PDF)

Overbias and Quantum Tunneling in Light-Emitting Memristors

Physical review applied, 2023-08, Vol.20 (2), Article 024057

2023

Volltextzugriff (PDF)

48 Amplification and overexpression of vinculin are associated with increased tumour cell proliferation and progression in advanced prostate cancer

European journal of cancer supplements, 2010, Vol.8 (5), p.13-13

2010

Volltextzugriff (PDF)

Expression patterns of potential therapeutic targets in prostate cancer

International journal of cancer, 2005-02, Vol.113 (4), p.619-628

2005

Volltextzugriff (PDF)

Activation of Signal Transducer and Activator of Transcription-5 in Prostate Cancer Predicts Early Recurrence

Clinical cancer research, 2005-08, Vol.11 (16), p.5863-5868

2005

Volltextzugriff (PDF)

Financial Management of Family Businesses: Transparency – Compliance - Performance – Strategy - Governance

Volltextzugriff (PDF)

Clusterin expression is significantly enhanced in prostate cancer cells following androgen withdrawal therapy

The Prostate, 2002-02, Vol.50 (3), p.179-188

2002

Volltextzugriff (PDF)

Enhanced Radiation Sensitivity in Prostate Cancer by Inhibition of the Cell Survival Protein Clusterin

Clinical cancer research, 2002-10, Vol.8 (10), p.3276-3284

2002

Volltextzugriff (PDF)

Strong COX-2-expression in hormone-refractory and metastatic prostate cancer — a potential therapeutic target

Pathology, research and practice, 2004, Vol.200 (4), p.271-272

2004

Volltextzugriff (PDF)

Multiprobe FISH for enhanced prediction of recurrent bladder cancer

Pathology, research and practice, 2004, Vol.200 (4), p.295-295

2004

Volltextzugriff (PDF)

Randomised trials in German-language journals

The Lancet (British edition), 1996-04, Vol.347 (9007), p.1047-1048

1996

Volltextzugriff (PDF)

1 – 25 von 1.903

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.350)
Mit Volltextzugriff
(1.393)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

3 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(944)
Humans
(875)
Life Sciences & Biomedicine
(829)
Male
(486)
Female
(435)
Adult
(267)
Middle Aged
(266)
Aged
(210)
Biological And Medical Sciences
(199)
Medical Sciences
(189)
General & Internal Medicine
(143)
Medicine, General & Internal
(117)
Cardiovascular System & Cardiology
(114)
Adolescent
(113)
Cardiac & Cardiovascular Systems
(107)
Child
(105)
Respiratory System
(102)
Physical Sciences
(101)
Risk Factors
(95)
Animals
(86)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(14)

Menü

Weitere Dienste

Einstellungen

Transgenerational entrepreneurship: exploring growth and performance in family firms across generations

Advancing patient-derived organoids of prostate cancer for disease modeling and personalized medicine

627: MED12 overexpression is a frequent event in castration-resistant prostate cancer

Incidental prostate cancer prevalence at radical cystoprostatectomy—importance of the histopathological work-up

ERG rearrangement and protein expression in the progression to castration-resistant prostate cancer

319 COMPREHENSIVE ANALYSIS OF THE TMPRSS2-ERG TRANSLOCATION DURING PROSTATE CANCER PROGRESSION

Overexpression of the cytoprotective protein clusterin decreases radiosensitivity in the human LNCaP prostate tumour model

P213 - Loss of MTAP expression by immunohistochemistry is a surrogate marker for homozygous 9p21.3 deletion in urothelial carcinoma

Loss of MTAP expression by immunohistochemistry is a surrogate marker for homozygous 9p21.3 deletion in urothelial carcinoma

Parental divorce in early life and entrepreneurial performance in adulthood

Language bias in randomised controlled trials published in English and German

A0535 - Cell-Free DNA genomic profiling and its clinical implementation in advanced prostate cancer

Cell-Free DNA genomic profiling and its clinical implementation in advanced prostate cancer

Stat3 Promotes Metastatic Progression of Prostate Cancer

Financial Management of Family Businesses: Transparency - Compliance - Performance - Strategy - Governance

Overbias and Quantum Tunneling in Light-Emitting Memristors

48 Amplification and overexpression of vinculin are associated with increased tumour cell proliferation and progression in advanced prostate cancer

Expression patterns of potential therapeutic targets in prostate cancer

Activation of Signal Transducer and Activator of Transcription-5 in Prostate Cancer Predicts Early Recurrence

Financial Management of Family Businesses: Transparency – Compliance - Performance – Strategy - Governance

Clusterin expression is significantly enhanced in prostate cancer cells following androgen withdrawal therapy

Enhanced Radiation Sensitivity in Prostate Cancer by Inhibition of the Cell Survival Protein Clusterin

Strong COX-2-expression in hormone-refractory and metastatic prostate cancer — a potential therapeutic target

Multiprobe FISH for enhanced prediction of recurrent bladder cancer

Randomised trials in German-language journals

Suchergebnisse filtern